Zhejiang Huahai Pharmaceutical Co Ltd - Asset Resilience Ratio

Latest as of March 2026: 0.35%

Zhejiang Huahai Pharmaceutical Co Ltd (600521) has an Asset Resilience Ratio of 0.35% as of March 2026. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. Check asset allocation strategy of Zhejiang Huahai Pharmaceutical Co Ltd to assess the company's strategic physical and investment asset allocation.

Liquid Assets

CN¥77.47 Million

≈ $11.34 Million USD Cash + Short-term Investments

Total Assets

CN¥22.22 Billion

≈ $3.25 Billion USD All company assets

Resilience Assessment

Low

Financial Resilience Level

Asset Resilience Ratio Trend (2003–2025)

This chart shows how Zhejiang Huahai Pharmaceutical Co Ltd's Asset Resilience Ratio has changed over time. See Zhejiang Huahai Pharmaceutical Co Ltd balance sheet independence to measure how much of total assets are equity-financed.

Liquid Assets Composition Over Time

This chart breaks down Zhejiang Huahai Pharmaceutical Co Ltd's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see Zhejiang Huahai Pharmaceutical Co Ltd market capitalisation.

Current Liquid Assets Breakdown

Component	Amount	% of Total Assets
Cash & Equivalents	CN¥0.00	0%
Short-term Investments	CN¥77.47 Million	0.35%
Total Liquid Assets	CN¥77.47 Million	0.35%

Asset Resilience Insights

Limited Liquidity: Zhejiang Huahai Pharmaceutical Co Ltd maintains only 0.35% of assets in liquid form.
This low level may indicate efficient asset utilization but could pose risks during economic downturns.
The company has significant short-term investments, indicating active treasury management.

Zhejiang Huahai Pharmaceutical Co Ltd Industry Peers by Asset Resilience Ratio

Compare Zhejiang Huahai Pharmaceutical Co Ltd's asset resilience ratio with other companies in the same industry.

Company	Industry	Asset Resilience Ratio
Haleon plc NYSE:HLN	Drug Manufacturers - Specialty & Generic	4.06%
Viatris Inc NASDAQ:VTRS	Drug Manufacturers - Specialty & Generic	0.29%
Neuland Laboratories Limited NSE:NEULANDLAB	Drug Manufacturers - Specialty & Generic	6.06%
Ningbo Menovo Pharm Co Ltd SHG:603538	Drug Manufacturers - Specialty & Generic	3.28%
Shenzhen Chipscreen Biosciences Co SHG:688321	Drug Manufacturers - Specialty & Generic	5.10%
Tianjin Ringpu Bio Tech SHE:300119	Drug Manufacturers - Specialty & Generic	14.27%
China Animal Husbandry Industry Co Ltd SHG:600195	Drug Manufacturers - Specialty & Generic	3.81%
Shandong Shanda Wit Science and Technology Co Ltd SHE:000915	Drug Manufacturers - Specialty & Generic	25.22%

Annual Asset Resilience Ratio for Zhejiang Huahai Pharmaceutical Co Ltd (2003–2025)

The table below shows the annual Asset Resilience Ratio data for Zhejiang Huahai Pharmaceutical Co Ltd.

Year	Asset Resilience Ratio (%)	Liquid Assets	Total Assets	Change
2025-12-31	0.35%	CN¥75.98 Million ≈ $11.12 Million	CN¥21.50 Billion ≈ $3.15 Billion	+0.05pp
2024-12-31	0.30%	CN¥60.79 Million ≈ $8.90 Million	CN¥20.26 Billion ≈ $2.96 Billion	-0.20pp
2023-12-31	0.50%	CN¥93.04 Million ≈ $13.61 Million	CN¥18.60 Billion ≈ $2.72 Billion	-0.29pp
2022-12-31	0.79%	CN¥143.07 Million ≈ $20.94 Million	CN¥18.15 Billion ≈ $2.66 Billion	+0.78pp
2021-12-31	0.01%	CN¥1.01 Million ≈ $148.09K	CN¥15.47 Billion ≈ $2.26 Billion	+0.01pp
2018-12-31	0.00%	CN¥2.05K ≈ $299.56	CN¥10.37 Billion ≈ $1.52 Billion	-3.92pp
2014-12-31	3.92%	CN¥177.00 Million ≈ $25.90 Million	CN¥4.51 Billion ≈ $659.96 Million	+3.58pp
2013-12-31	0.35%	CN¥15.60 Million ≈ $2.28 Million	CN¥4.47 Billion ≈ $653.53 Million	+0.18pp
2012-12-31	0.17%	CN¥5.43 Million ≈ $794.07K	CN¥3.22 Billion ≈ $470.69 Million	-0.05pp
2011-12-31	0.21%	CN¥5.53 Million ≈ $809.36K	CN¥2.58 Billion ≈ $377.10 Million	-10.70pp
2004-12-31	10.91%	CN¥97.71 Million ≈ $14.30 Million	CN¥895.55 Million ≈ $131.05 Million	+9.36pp
2003-12-31	1.55%	CN¥12.01 Million ≈ $1.76 Million	CN¥774.68 Million ≈ $113.36 Million	--

pp = percentage points

About Zhejiang Huahai Pharmaceutical Co Ltd

SHG:600521 China Drug Manufacturers - Specialty & Generic

Market Cap

$3.36 Billion

CN¥22.98 Billion CNY

Market Cap Rank

#4651 Global

#826 in China

Share Price

CN¥15.35

Change (1 day)

-2.29%

52-Week Range

CN¥14.46 - CN¥27.01

All Time High

CN¥43.62